138 related articles for article (PubMed ID: 18181252)
21. Two single-center, double-blind, randomized, placebo-controlled, phase I studies to investigate the tolerability and pharmacokinetics of CH-1504, an antifolate, in healthy male subjects.
Mant T; Jurcevic S; Szakacs C; Adams L; Boland J; Hewitt LA
Clin Ther; 2008 Jan; 30(1):131-42. PubMed ID: 18343249
[TBL] [Abstract][Full Text] [Related]
22. Diazepam dose-dependently increases or decreases implicit priming of alcohol associations in problem drinkers.
Zack M; Poulos CX; Woodford TM
Alcohol Alcohol; 2006; 41(6):604-10. PubMed ID: 17020910
[TBL] [Abstract][Full Text] [Related]
23. Effects of acute oral Delta9-tetrahydrocannabinol and standardized cannabis extract on the auditory P300 event-related potential in healthy volunteers.
Roser P; Juckel G; Rentzsch J; Nadulski T; Gallinat J; Stadelmann AM
Eur Neuropsychopharmacol; 2008 Aug; 18(8):569-77. PubMed ID: 18544469
[TBL] [Abstract][Full Text] [Related]
24. Early clinical pharmacological trials with a new anti-epileptic, milacemide, using pharmaco-EEG and psychometry.
Saletu B; Grünberger J
Methods Find Exp Clin Pharmacol; 1984 Jun; 6(6):317-30. PubMed ID: 6431211
[TBL] [Abstract][Full Text] [Related]
25. Pharmacodynamic and pharmacokinetic effects of MK-0343, a GABA(A) alpha2,3 subtype selective agonist, compared to lorazepam and placebo in healthy male volunteers.
de Haas SL; de Visser SJ; van der Post JP; Schoemaker RC; van Dyck K; Murphy MG; de Smet M; Vessey LK; Ramakrishnan R; Xue L; Cohen AF; van Gerven JM
J Psychopharmacol; 2008 Jan; 22(1):24-32. PubMed ID: 18187530
[TBL] [Abstract][Full Text] [Related]
26. [Clinical and EEG/ERP brain mapping studies with vigabatrin in therapy refractory epileptic patients].
Pfersmann D; Saletu B; Semlitsch HV; Anderer P; Dieterich HA
Wien Med Wochenschr; 1993; 143(6):119-28. PubMed ID: 8517061
[TBL] [Abstract][Full Text] [Related]
27. Anti-diuretic for operational aircrew: effects of desmopressin on urine flow, cognition, and sleepiness.
Nicholson AN; Turner C
Aviat Space Environ Med; 2005 Aug; 76(8):760-5. PubMed ID: 16110692
[TBL] [Abstract][Full Text] [Related]
28. Effect of levetiracetam on cardiac repolarization in healthy subjects: a single-dose, randomized, placebo- and active-controlled, four-way crossover study.
Hulhoven R; Rosillon D; Bridson WE; Meeus MA; Salas E; Stockis A
Clin Ther; 2008 Feb; 30(2):260-70. PubMed ID: 18343264
[TBL] [Abstract][Full Text] [Related]
29. Brain potential changes after intranasal vs. intravenous administration of vasopressin: evidence for a direct nose-brain pathway for peptide effects in humans.
Pietrowsky R; Strüben C; Mölle M; Fehm HL; Born J
Biol Psychiatry; 1996 Mar; 39(5):332-40. PubMed ID: 8704064
[TBL] [Abstract][Full Text] [Related]
30. Effects of twenty-minute 3G mobile phone irradiation on event related potential components and early gamma synchronization in auditory oddball paradigm.
Stefanics G; Thuróczy G; Kellényi L; Hernádi I
Neuroscience; 2008 Nov; 157(2):453-62. PubMed ID: 18835335
[TBL] [Abstract][Full Text] [Related]
31. [The cognitive effect of alprazolam in healthy volunteers].
Drabant S; Tömlo J; Tóth M; Péterfai E; Klebovich I
Acta Pharm Hung; 2006; 76(1):25-31. PubMed ID: 17094673
[TBL] [Abstract][Full Text] [Related]
32. Effect of perospirone on P300 electrophysiological activity and social cognition in schizophrenia: a three-dimensional analysis with sloreta.
Sumiyoshi T; Higuchi Y; Itoh T; Matsui M; Arai H; Suzuki M; Kurachi M; Sumiyoshi C; Kawasaki Y
Psychiatry Res; 2009 Jun; 172(3):180-3. PubMed ID: 19386475
[TBL] [Abstract][Full Text] [Related]
33. Electrical sources of P300 event-related brain potentials revealed by low resolution electromagnetic tomography. 2. Effects of nootropic therapy in age-associated memory impairment.
Anderer P; Saletu B; Semlitsch HV; Pascual-Marqui RD
Neuropsychobiology; 1998; 37(1):28-35. PubMed ID: 9438269
[TBL] [Abstract][Full Text] [Related]
34. Anxiolytic effects of a combination of Melissa officinalis and Valeriana officinalis during laboratory induced stress.
Kennedy DO; Little W; Haskell CF; Scholey AB
Phytother Res; 2006 Feb; 20(2):96-102. PubMed ID: 16444660
[TBL] [Abstract][Full Text] [Related]
35. Randomized, crossover, single-blind, placebo-controlled, human pharmacology clinical trial with desoxypeganine, a new cholinesterase and selective MAO-A inhibitor: multiple-dose pharmacokinetics.
Algorta J; Pena MA; Alvarez A; Maraschiello C; Maruhn D; Windisch M; Mucke HA
Int J Clin Pharmacol Ther; 2009 Jul; 47(7):483-90. PubMed ID: 19640356
[TBL] [Abstract][Full Text] [Related]
36. The cognitive effects of modulating the glycine site of the NMDA receptor with high-dose glycine in healthy controls.
Palmer C; Ellis KA; O'Neill BV; Croft RJ; Leung S; Oliver C; Wesnes KA; Nathan PJ
Hum Psychopharmacol; 2008 Mar; 23(2):151-9. PubMed ID: 17972276
[TBL] [Abstract][Full Text] [Related]
37. Electrophysiological neuroimaging of the central effects of S-adenosyl-L-methionine by mapping of electroencephalograms and event-related potentials and low-resolution brain electromagnetic tomography.
Saletu B; Anderer P; Di Padova C; Assandri A; Saletu-Zyhlarz GM
Am J Clin Nutr; 2002 Nov; 76(5):1162S-71S. PubMed ID: 12418497
[TBL] [Abstract][Full Text] [Related]
38. Perceiving rhythm where none exists: event-related potential (ERP) correlates of subjective accenting.
Potter DD; Fenwick M; Abecasis D; Brochard R
Cortex; 2009 Jan; 45(1):103-9. PubMed ID: 19027894
[TBL] [Abstract][Full Text] [Related]
39. A randomized, double-blind, placebo-controlled study of preemptively administered intravenous parecoxib: effect on anxiety levels and procedural pain during epidural catheter placement for surgical operations or for chronic pain therapy.
Vadalouca A; Moka E; Chatzidimitriou A; Siafaka I; Sikioti P; Argyra E
Pain Pract; 2009; 9(3):181-94. PubMed ID: 19298364
[TBL] [Abstract][Full Text] [Related]
40. Acute effects of the anxiolytics suriclone and alprazolam on cognitive information processing utilizing topographic mapping of event-related brain potentials (P300) in healthy subjects.
Semlitsch HV; Anderer P; Saletu B
Eur J Clin Pharmacol; 1995; 49(3):183-91. PubMed ID: 8665994
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
